Less Ads, More Data, More Tools Register for FREE

Pin to quick picks4Imprint Regulatory News (FOUR)

Share Price Information for 4Imprint (FOUR)

Share Price is delayed by 15 minutes
Get Live Data
3,748.00    -12.00 (-0.32%)
Bid:
3,748.00
Ask:
3,752.00
Spread: 4.00 (0.107%)
Market Cap: £1.05b
FOUR Live PriceLast checked at - London Stock Exchange

Intraday 4Imprint Share Chart

Trading Statement

12 Nov 2024 07:00

RNS Number : 7756L
4imprint Group PLC
12 November 2024
 

12 November 2024

4imprint Group plc ("4imprint" or the "Group")

Update on Current Trading

 

4imprint today provides a scheduled update on the Group's trading and operations.

 

The Group has delivered a strong financial performance in difficult market conditions in the 10 month period up to the end of October 2024.

 

The Board is pleased to update the full year 2024 financial guidance given with the Interim results on 7 August 2024. Expectations for Group profit before tax remain unchanged and are within the current range of analysts' forecasts at just over $150m. Group revenue is expected to be around $1.37bn.

 

October year to date total order count was 2% higher than prior year. New customer orders were 9% below prior year to date, but encouragingly existing customer orders were up 6%, reflecting the quality of customers acquired under the new marketing mix. Combined with strong average order values at 2% above prior year, overall order revenue was 4% above the same time period in 2023.

 

The promotional products industry in our primary North American market has continued to present a challenging trading backdrop. Continuing uncertainty around economic conditions has translated into generally weaker levels of corporate confidence, compounded by specific macro factors over which the Group has no control, including elevated interest rates, severe weather events and the distraction arising from the US election cycle.

 

Although these factors have resulted in some pressure on revenue, performance across the remainder of the business has been very satisfactory. In particular, gross profit margin has remained strong at around 32% and the resilience and flexibility of the new marketing mix has enabled us to be agile in tailoring our marketing investment to the prevailing market conditions. The resulting double digit operating profit margin is a key factor underpinning our Group profit before tax performance.

 

With a cash balance of $137m at the end of October 2024, the Group remains highly cash generative and well financed.

 

Our experience is that less buoyant economic conditions represent a market share opportunity for 4imprint as our financial strength allows us to keep investing in the business and to take full advantage of the market recovery when it arrives.

 

The Board remains very confident in the Group's strategy, positioning and prospects.

 

 

For further information, please contact:

 

4imprint Group plc

MHP Group

Tel: + 44 (0) 20 3709 9680

Tel: + 44 (0) 7884 494112

Kevin Lyons-Tarr, Chief Executive Officer

Katie Hunt

David Seekings, Chief Financial Officer

Eleni Menikou

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTDFLFFZFLBFBX
Date   Source Headline
2nd Apr 20203:34 pmRNSDirector/PDMR Shareholding
1st Apr 202012:03 pmRNSPrice Monitoring Extension
30th Mar 202011:02 amRNSAnnual Financial Report
30th Mar 20208:32 amRNSHolding(s) in Company
26th Mar 202011:43 amRNSHolding(s) in Company
24th Mar 20203:09 pmRNSHolding(s) in Company
24th Mar 202012:02 pmRNSPrice Monitoring Extension
23rd Mar 20204:38 pmRNSPrice Monitoring Extension
20th Mar 202010:15 amRNSPrice Monitoring Extension
19th Mar 20207:00 amRNSCOVID-19 Update
13th Mar 20204:36 pmRNSPrice Monitoring Extension
5th Mar 20204:25 pmRNSHolding(s) in Company
5th Mar 20208:49 amRNSHolding(s) in Company
3rd Mar 20202:38 pmRNSHolding(s) in Company
3rd Mar 20207:00 amRNSFinal Results
26th Feb 20203:55 pmRNSHolding(s) in Company
16th Jan 20207:00 amRNSTrading Update and Notice of Final Results
30th Dec 20197:00 amRNSDirectorate Change
23rd Dec 20192:53 pmRNSHolding(s) in Company
18th Dec 20192:46 pmRNSHolding(s) in Company
17th Dec 20193:01 pmRNSEBT Purchase
6th Nov 20198:30 amRNSHolding(s) in Company
5th Nov 20194:24 pmRNSEBT Purchase
4th Nov 20197:00 amRNSTrading Update
29th Oct 20199:01 amRNSEBT Purchase
25th Oct 20199:22 amRNSHolding(s) in Company
17th Oct 20193:51 pmRNSHolding(s) in Company
3rd Oct 20193:55 pmRNSHolding(s) in Company
3rd Oct 20191:14 pmRNSEBT Purchase
2nd Oct 20194:59 pmRNSHolding(s) in Company
30th Sep 201910:30 amRNSDirector/PDMR Shareholding
13th Sep 20194:38 pmRNSHolding(s) in Company
9th Sep 20199:11 amRNSEBT Purchase
27th Aug 20192:42 pmRNSDirector/PDMR Shareholding
14th Aug 20199:48 amRNSHolding(s) in Company
31st Jul 20197:00 amRNSHalf-year Report
29th Jul 20198:55 amRNSHolding(s) in Company
12th Jul 20194:28 pmRNSHolding(s) in Company
1st Jul 201910:03 amRNSDirector/PDMR Shareholding
25th Jun 20199:11 amRNSHolding(s) in Company
14th Jun 20199:25 amRNSEBT Purchase
20th May 201911:18 amRNSEBT purchase
7th May 20192:21 pmRNSResult of AGM
7th May 20197:00 amRNSAGM Statement
24th Apr 201911:56 amRNSEBT Purchase
4th Apr 201911:21 amRNSHolding(s) in Company
4th Apr 201911:09 amRNSDirector/PDMR Shareholding
3rd Apr 20198:29 amRNSHolding(s) in Company
1st Apr 20193:57 pmRNSAnnual Financial Report
28th Mar 20193:13 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.